Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,626 | 56,006 | 70,971 | 60,532 | 119,017 |
| Marketable Securities | 182,118 | 167,626 | 157,389 | 181,370 | 133,191 |
| TOTAL | $220,738 | $226,241 | $231,726 | $244,466 | $255,034 |
| Non-Current Assets | |||||
| PPE Net | 636 | 616 | 574 | 617 | 594 |
| Other Non-Current Assets | 592 | 726 | 888 | 3,473 | 3,124 |
| TOTAL | $1,228 | $1,342 | $1,462 | $4,090 | $3,718 |
| Total Assets | $221,966 | $227,583 | $233,188 | $248,556 | $258,752 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,565 | 3,498 | 2,154 | 10,945 | 9,821 |
| TOTAL | $6,725 | $3,715 | $2,391 | $11,180 | $10,054 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 37 | 92 | 146 |
| TOTAL | $N/A | $N/A | $37 | $92 | $146 |
| Total Liabilities | $6,725 | $3,715 | $2,428 | $11,272 | $10,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,942 | 96,895 | 96,502 | 95,997 | 95,568 |
| Common Shares | 10 | 10 | 10 | 9 | 9 |
| Retained earnings | -154,111 | -141,595 | -131,303 | -124,135 | -109,269 |
| Other shareholders' equity | -145 | -124 | 49 | -161 | -180 |
| TOTAL | $215,241 | $223,868 | $230,760 | $237,284 | $248,552 |
| Total Liabilities And Equity | $221,966 | $227,583 | $233,188 | $248,556 | $258,752 |